The role of vitamin D in vascular calcification in chronic kidney disease

Seminars in Dialysis

Volumn 18, Issue 4, 2005, Pages 307-314

  Wolisi, Godwin O ^a   Moe, Sharon M ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; PARATHYROID HORMONE; VITAMIN D;

ANIMAL; ARTERIOSCLEROSIS; ARTICLE; BONE; CALCINOSIS; CHRONIC KIDNEY FAILURE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; SECONDARY HYPERPARATHYROIDISM;

ANIMALS; ARTERIOSCLEROSIS; BONE AND BONES; CALCINOSIS; CALCITRIOL; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; PARATHYROID HORMONE; RENAL DIALYSIS; VITAMIN D;

EID: 23844437946     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2005.18407.x     Document Type: Article

References (110)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112-S119, 1998
2. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58:353-362, 2000
3. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607-617, 1998
4. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208-2218, 2004
5. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK: Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131-2138, 2001
6. Stary HC: Natural history of calcium deposits in atherosclerosis progression and regression. Z Kardiol 89(suppl 2):28-35, 2000
7. Stary HC: Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol 20:1177-1178, 2000
8. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20:1262-1275, 2000
9. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 265:3255-3264, 1991
10. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D: Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 100:354-360, 1999
11. Miwa Y, Tsushima M, Arima H, Kawano Y, Sasaguri T: Pulse pressure is an independent predictor for the progression of aortic wall calcification in patients with controlled hyperlipidemia. Hypertension 43:536-540, 2004
12. Proudfoot D, Shanahan CM, Weissberg PL: Vascular calcification: new insights into an old problem [editorial; comment]. J Pathol 185:1-3, 1998
13. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M: Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 16:978-983, 1996
14. Niskanen L, Siitonen O, Suhonen M, Uusitupa MI: Medial artery calcification predicts cardiovascular mortality in patients with NIDDM. Diabetes Care 17:1252-1256, 1994
15. Raggi P: Imaging of cardiovascular calcifications with electron beam tomography in hemodialysis patients. Am J Kidney Dis 37:S62-S65, 2001
16. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731-1740, 2003
17. Ibels LS, Alfrey AC, Huffer WE, Craswell PW, Anderson JT, Weil RD: Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 66:790-796, 1979
18. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, Mall G, Amann K: Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 15:218-223, 2000
19. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394-401, 1996
20. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483, 2000
21. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F: Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100-105, 2002
22. Moe SM, O'Neill KD, Fineberg N, Persohn S, Ahmed S, Garrett P, Meyer CA: Assessment of vascular calcification in ESRD patients using spiral CT. Nephrol Dial Transplant 18:1152-1158, 2003
23. Hujairi NM, Afzali B, Goldsmith DJ: Cardiac calcification in renal patients: what we do and don't know. Am J Kidney Dis 43:234-243, 2004
24. Moe SM, O'Neill KD, Reselerova M, Fineberg N, Persohn S, Meyer C: Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant 19:2387-2393, 2004
25. Shemesh J, Apter S, Itzchak Y, Motro M: Coronary calcification compared in patients with acute versus in those with chronic coronary events by using dual-sector spiral CT. Radiology 226:483-488, 2003
26. Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Goncalves M, Negrao AP: A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 9:1480-1488, 2004
27. Guerin AP, London GM, Marchais SJ, Metivier F: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15:1014-1021, 2000
28. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938-942, 2001
29. Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, Lazarus JM, Owen WF Jr:. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287:1548-1555, 2002
30. Kimura K, Saika Y, Otani H, Fujii R, Mune M, Yukawa S: Factors associated with calcification of the abdominal aorta in hemodialysis patients. Kidney Int Suppl 71:S238-S241, 1999
31. Moe SM, Chen NX: Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis. Pediatr Nephrol 18:969-975, 2003
32. Banks LM, Lees B, MacSweeney JE, Stevenson JC: Effect of degenerative spinal and aortic calcification on bone density measurements in postmenopausal women: links between osteoporosis and cardiovascular disease? Eur J Clin Invest 24:813-817, 1994
33. Kiel DP, Hannan MT, Cupple LA, Wilson PWF, Levy D, Clouse MF, Krueger-Lovy K, O'Donnell CJ: Low bone mineral density (BMD) is associated with coronary artery calcification. J Bone Miner Res 15:S160, 2000
34. Boukhris R, Becker KL: Calcification of the aorta and osteoporosis. A roentgenographic study. JAMA 219:1307-1311, 1972
35. Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O'Donnell CJ, Wilson PW: Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif Tissue Int 68:271-276, 2001
36. Hak AE, Pols HA, van Hemert AM, Hofman A, Witteman JC: Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol 20:1926-1931, 2000
37. Garraway WM, Stauffer RN, Kurland LT, O'Fallon WM: Limb fractures in a defined population. I. Frequency and distribution. Mayo Clin Proc 54:701-707, 1979
38. Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, Rumberger J, Stanford W, White R, Taubert K: Coronary artery calcification. pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association Writing Group. Circulation 94:1175-1192, 1996
39. Drake TA, Schadt E, Hannani K, Kabo JM, Krass K, Colinayo V, Greaser LE III, Goldin J, Lusis AJ: Genetic loci determining bone density in mice with diet-induced atherosclerosis. Physiol Genomics 5:205-215, 2001
40. Wallin R, Wajih N, Greenwood GT, Sane DC: Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Med Res Rev 21:274-301, 2001
41. Hutchison AJ, Whitehouse RW, Boulton HF, Adams JE, Mawer EB, Freemont TJ, Gokal R: Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 44:1071-1077, 1993
42. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, De Vernejoul MC: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15:1943-1951, 2004
43. Kurz P, Monier-Faugere MC, Bognar B, Werner E, Roth P, Vlachojannis J, Malluche HH: Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 46:855-861, 1994
44. Price PA, June HH, Buckley JR, Williamson MK: Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 21:1610-1616, 2001
45. Price PA, Buckley JR, Williamson MK: The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats. J Nutr 131:2910-2915, 2001
46. Price PA, Faus SA, Williamson MK: Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 21:817-824, 2001
47. Price PA, June HH, Buckley JR, Williamson MK: SB 242784, a selective inhibitor of the osteoclastic V-H+ATPase, inhibits arterial calcification in the rat. Circ Res 91:547-552, 2002
48. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL: Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91:1800-1809, 1993
49. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT: Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 94:1597-1604, 1994
50. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL: High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93:2393-2402, 1994
51. Nakaoka T, Gonda K, Ogita T, Otawara-Hamamoto Y, Okabe F, Kira Y, Harii K, Miyazono K, Takuwa Y, Fujita T: Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J Clin Invest 100:2824-2832, 1997
52. Proudfoot D, Skepper JN, Shanahan CM, Weissberg PL: Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Biol 18:379-388, 1998
53. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME: Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100:2168-2176, 1999
54. Mori K, Shioi A, Jono S, Nishizawa Y, Morii H: Dexamethasone enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19:2112-2118, 1999
55. Wada T, McKee MD, Steitz S, Giachelli CM: Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 84:166-178, 1999
56. Doherty MJ, Canfield AE: Gene expression during vascular pericyte differentiation. Crit Rev Eukaryot Gene Expr 9:1-17, 1999
57. Bostrom KI: Cell differentiation in vascular calcification. Z Kardiol 89(suppl 2):69-74, 2000
58. Canfield AE, Allen TD, Grant ME, Schor SL, Schor AM: Modulation of extracellular matrix biosynthesis by bovine retinal pericytes in vitro: effects of the substratum and cell density. J Cell Sci 96:159-169, 1990
59. Jono S, Peinado C, Giachelli CM: Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 275:20197-20203, 2000
60. Yang H, Curinga G, Giachelli CM: Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int 66:2293-2299, 2004
61. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM: Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15:2857-2867, 2004
62. Parhami F, Bostrom K, Watson K, Demer LL: Role of molecular regulation in vascular calcification. J Atheroscler Thromb 3:90-94, 1996
63. Moe SM, Duan D, Doehle BP, O'Neill KD, Chen NX: Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 63:1003-1011, 2003
64. Ahmed S, O'Neill KD, Hood AF, Evan AP, Moe SM: Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis 37:1267-1276, 2001
65. Chen N, Moe S: Vascular calcification in chronic kidney disease. Semin Nephrol 24:61-68, 2004
66. Chen NX, O'Neill KD, Duan D, Moe SM: Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 62:1724-1731, 2002
67. Moe SM, Chen NX: Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 95:560-567, 2004
68. 2+-uptake by cultured vascular smooth muscle cells derived from rat aorta. Biochem Biophys Res Commun 152:1388-1394, 1988
69. Rajasree S, Umashankar PR, Lal AV, Sarma PS, Kartha CC: 1,25-dihydroxyvitamin D3 receptor is upregulated in aortic smooth muscle cells during hypervitaminosis D. Life Sci 70:1777-1788, 2002
70. MacCarthy EP, Yamashita W, Hsu A, Ooi BS: 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 13:954-959, 1989
71. Rebsamen MC, Sun J, Norman AW, Liao JK: 1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res 91:17-24, 2002
72. Tukaj C, Kubasik-Juraniec J, Kraszpulski M: Morphological changes of aortal smooth muscle cells exposed to calcitriol in culture. Med Sci Monit 6:668-674, 2000
73. Cardus A, Gallego C, Muray S, Marco MP, Parisi E, Aldea M, Fernandez E: [Differential effect of vitamin D analogues on the proliferation of vascular smooth muscle cells]. Nefrologia 23(suppl 2):117-121, 2003
74. Jono S, Nishizawa Y, Shioi A, Morii H: 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98:1302-1306, 1998
75. Jono S, Nishizawa Y, Shioi A, Morii H: Parathyroid hormone-related peptide as a local regulator of vascular calcification. Its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17:1135-1142, 1997
76. Massfelder T, Helwig JJ, Stewart AF: Parathyroid hormone-related protein as a cardiovascular regulatory peptide. Endocrinology 137:3151-3153, 1996
77. Nakayama H, Taneda S, Kuwajima S, Aoki S, Kuroda Y, Misawa K, Nakagawa S: Production and characterization of antibodies to advanced glycation products on proteins. Biochem Biophys Res Commun 162:740-745, 1989
78. Ozeki S, Ohtsuru A, Seto S, Takeshita S, Yano H, Nakayama T, Ito M, Yokota T, Nobuyoshi M, Segre GV, Yamashita S, Yano K: Evidence that implicates the parathyroid hormone-related peptide in vascular stenosis. Increased gene expression in the intima of injured carotid arteries and human restenotic coronary lesions. Arterioscler Thromb Vasc Biol 16:565-575, 1996
79. Niederhoffer N, Bobryshev YV, Lartaud-Idjouadiene I, Giummelly P, Atkinson J: Aortic calcification produced by vitamin D3 plus nicotine. J Vasc Res 34:386-398, 1997
80. Niederhoffer N, Lartaud-Idjouadiene I, Giummelly P, Duvivier C, Peslin R, Atkinson J: Calcification of medial elastic fibers and aortic elasticity. Hypertension 29:999-1006, 1997
81. Quaglia NB, Brandoni A, Villar SR, Torres AM: Haemodynamic and tubular renal dysfunction in rats with sustained arterial calcinosis. Clin Exp Pharmacol Physiol 31:231-236, 2004
82. Kieffer P, Robert A, Capdeville-Atkinson C, Atkinson J, Lartaud-Idjouadiene I: Age-related arterial calcification in rats. Life Sci 66:2371-2381, 2000
83. Marque V, Van Essen H, Struijker-Boudier HA, Atkinson J, Lartaud-Idjouadiene I: Determination of aortic elastic modulus by pulse wave velocity and wall tracking in a rat model of aortic stiffness. J Vasc Res 38:546-550, 2001
84. Davies MR, Lund RJ, Hruska KA: BMP-7 Is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol 14:1559-1567, 2003
85. Hruska KA, Saab G, Chaudhary LR, Quinn CO, Lund RJ, Surendran K: Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy. Semin Nephrol 24:25-38, 2004
86. Cozzolino M, Dusso AS, Liapis H, Finch J, Lu Y, Burke SK, Slatopolsky E: The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats. J Am Soc Nephrol 13:2299-2308, 2002
87. Katsumata K, Kusano K, Hirata M, Tsunemi K, Nagano N, Burke SK, Fukushima N: Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Kidney Int 64:441-450, 2003
88. Tvedegaard E, Falk E, Nielsen M: Uremic arterial disease in rabbits with special reference to the coronary arteries. Acta Pathol Microbiol Immunol Scand [A] 93:81-88, 1985
89. Krog M, Ejerblad S, Eriksson I, Johansson H: Arterial calcifications in uraemic rats treated with 1-alpha-hydroxycholecalciferol and parathyroidectomy. Scand J Urol Nephrol 18:227-239, 1984
90. Hirata M, Katsumata K, Endo K, Fukushima N, Ohkawa H, Fukagawa M: In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3. Nephrol Dial Transplant 18:1770-1776, 2003
91. Martin D, Colloton R, Cattley R, Shatzen E, Lacey D: 1,25- dihydroxyvitamin D3 but no cinacalcet HCl treatment mediates aortic mineralization in a rat model of secondary hyperparathyroidism [abstract]. J Am Soc Nephrol 14:693A, 2003
92. Rodriguez M, Mendoza FC, Aguilera-Tejero E, Estepa JC, Almaden Y, Quintero A, Martin D, Lopez I: The calcimimetic NPS R-568 decreases vascular calcification in uremic rats treated with calcitriol [abstract]. J Am Soc Nephrol 15:279-280, 2004
93. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL: Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96:1755-1760, 1997
94. Doherty TM, Tang W, Dascalos S, Watson KE, Demer LL, Shavelle RM, Detrano RC: Ethnic origin and serum levels of 1alpha,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation 96:1477-1481, 1997
95. Massry SG, Smogorzewski M: Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia. Semin Nephrol 14:219-231, 1994
96. Meema HE, Oreopoulos DG, Rapoport A: Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int 32:388-394, 1987
97. Nichols P, Owen JP, Ellis HA, Farndon JR, Kelly PJ, Ward MK: Parathyroidectomy in chronic renal failure: a nine-year follow-up study. Q J Med 77:1175-1193, 1990
98. Malmaeus J, Akerstrom G, Johansson H, Ljunghall S, Nilsson P, Selking O: Parathyroid surgery in chronic renal insufficiency. Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation to the forearm. Acta Chir Scand 148:229-238, 1982
99. Nitta K, Ishizuka T, Horita S, Hayashi T, Ajiro A, Uchida K, Honda K, Oba T, Kawashima A, Yumura W, Kabaya T, Akiba T, Nihei H: Soluble osteopontin and vascular calcification in hemodialysis patients. Nephron 89:455-458, 2001
100. Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, Fukiyama K: Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 38:64-69, 2001
101. Kudoh Y, Iimura O: Study on the atherosclerosis mechanism in chronic hemodialysis. Jpn Circ J 51:631-641, 1987
102. Goldsmith DJ, Covic A, Sambrook PA, Ackrill P: Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. Nephron 77:37-43, 1997
103. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:E10-E17, 2000
104. Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB: Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160-1166, 1994
105. Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252, 2002
106. Level C, Lasseur C, Delmas Y, Cazin MC, Vendrely B, Chauveau P, Gosse P, Combe C: Determinants of arterial compliance in patients treated by hemodialysis. Clin Nephrol 56:435-444, 2001
107. Moe SM, Chen NX: Vascular calcification in end stage renal disease. Clin Calcium 12:1367-1372, 2002
108. Rostand SG, Sanders C, Kirk KA, Rutsky EA, Fraser RG: Myocardial calcification and cardiac dysfunction in chronic renal failure. Am J Med 85:651-657, 1988
109. McCullough PA, Sandberg KR, Dumler F, Yanez JE: Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review. J Nephrol 17:205-215, 2004
110. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM: Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39:695-701, 2002